Bionics Consortium Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.32 Cr
as on 17-11-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.53 Cr
as on 17-11-2024
- Revenue 77.52%
(FY 2023)
- Profit 173.87%
(FY 2023)
- Ebitda 115.93%
(FY 2023)
- Net Worth 72.72%
(FY 2023)
- Total Assets 51.54%
(FY 2023)
About Bionics Consortium
The Corporate was formerly known as Bionics Projects Private Limited. The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.32 Cr.
The company currently has active open charges totaling ₹8.53 Cr.
Raj Bajpai, Vinayak Bajpai, Shruti Vashistha, and Two other members serve as directors at the Company.
- CIN/LLPIN
U41000DL2006PTC155024
- Company No.
155024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bionics Consortium Private Limited offer?
Bionics Consortium Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Water Treatment Chemicals, Water Treatment & Purification Plant, Effluent Treatment & Wastewater Treatment Plant, Autoclaves, Sterilizers & Incubators, Laboratory Autoclave & Sterilizers.
Who are the key members and board of directors at Bionics Consortium?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Bajpai  | Additional Director | 27-Oct-2006 | Current |
| Vinayak Bajpai | Additional Director | 27-Jan-2023 | Current |
| Shruti Vashistha | Additional Director | 10-Aug-2024 | Current |
| Usha Gupta | Director | 15-Nov-2022 | Current |
| Aastha Khetan | Director | 15-Nov-2022 | Current |
Financial Performance of Bionics Consortium.
Bionics Consortium Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 77.52% increase. The company also saw a substantial improvement in profitability, with a 173.87% increase in profit. The company's net worth Soared by an impressive increase of 72.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bionics Consortium?
In 2023, Bionics Consortium had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kartal Projects Private LimitedActive 14 years 5 monthsVinayak Bajpai and Shruti Vashistha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 May 2024 | ₹0.81 M | Open |
Canara Bank Creation Date: 28 Feb 2023 | ₹8.25 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Aug 2021 | ₹1.00 M | Open |
How Many Employees Work at Bionics Consortium?
Bionics Consortium has a workforce of 5 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bionics Consortium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bionics Consortium's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
